Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DE6GF4
|
|||
| Drug Name |
ZYH7
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Dyslipidemia [ICD-11: 5C80-5C81] | Phase 2 | [1] | |
| Lipid metabolism disorder [ICD-11: 5C52.Z] | Phase 2 | [2] | ||
| Company |
Zydus Cadila
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01539616) A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01539616) A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia. U.S. National Institutes of Health. | |||
| REF 3 | Clinical pipeline report, company report or official report of Zydus Cadila. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.